DNA X, Inc. Common Stock SONM
$3.39
-2.31%
at last close
Analyst Consensus
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2020-05-14 | B. Riley Securities |
Maintains | Buy | $700 → $300 |
| 2019-10-31 | Oppenheimer |
Downgrades | Outperform → Perform | — |
| 2019-09-11 | B. Riley Securities |
Maintains | Buy | $1800 → $700 |
| 2019-07-18 | B. Riley Securities |
Initiates coverage on | Buy | $1700 |
| 2019-07-09 | National Securities Corporation |
Upgrades | Neutral → Buy | $1700 |
| 2019-06-10 | National Securities Corporation |
Initiates coverage on | Neutral | — |
| 2019-06-04 | Oppenheimer |
Initiates coverage on | Outperform | $1800 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $3.39
- Market Cap
- $5.16 million
- 52-Week Range
- $2.52 – $16.97
- Average Volume
- 31K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.